Compare Eli Lilly And Co (LLY) vs Las Vegas Sands Corp. (LVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Las Vegas Sands Corp. — how do they compare? Eli Lilly And Co trades at $1,174.02 (market cap $1.02T), while Las Vegas Sands Corp. trades at $45.87 (market cap $30.36B). The key difference: Eli Lilly And Co is far larger — about 33.6× Las Vegas Sands Corp.'s market cap, and Las Vegas Sands Corp. pays the higher dividend (2.4%). Which is the better fit depends on your goals.
| LLY | LVS | |
|---|---|---|
Market Cap | $1.02T | $30.36B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.24K | $69.49 |
52-Week Low | $625.65 | $44.78 |
Enterprise Value | $1.06T | $42.75B |
Dividend Yield | 0.6% | 2.4% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner, Four Seasons Hotel Macao, and Parisian in Macao, and the Marina Bay Sands resort in Singapore. Its Venetian and Palazzo Las Vegas in the U.S. asets were sold to Apollo and VICI for $6.25 billion in 2022. We expect Sands to open a fourth tower in Singapore in 2026. After the sale of its Vegas assets, the company will generate all its EBITDA from Asia, with its casino operations generating the majority of sales.
Read more on LVS →
